Where Will the Growth Be for Drug Delivery Methods?

LONDON--(Business Wire)--
The Healthcare group at Frost & Sullivan
(http://www.healthcare.frost.com/) is pleased to announce that it will
be hosting an interactive analyst briefing on the European Drug
Delivery Market on 31 July 2008 at 3pm BST (2pm GMT).

Drug delivery is a fast growing and highly dynamic segment of the
pharmaceutical and biotechnology industry. A number of factors have
contributed to the growth of this area, including poor efficacies,
patent expirations and the urgent need for life cycle management for
current drugs.

"The demand for novel drug delivery systems is rising and
pharmaceutical companies have been involved in developing innovative
methods," observes Frost & Sullivan Industry Analyst Sylvia Miriyam
Findlay. "Impending patent expirations will stimulate a surge in novel
drug delivery methods for existing products, while sophisticated
reformulation will generate substantial revenues in the European
pharmaceutical market."

This briefing will provide an analysis of industry challenges in
this market, with particular focus on the two most important segments
- pulmonary and transdermal drug delivery. Pharmaceutical and
biotechnology companies and drug delivery companies will benefit from
the discussion which will also highlight potential opportunities.

Those interested in participating in this interactive webinar
should send an email to Patrick Cairns - Corporate Communications at
patrick.cairns@frost.com with the following information: full name,
company name, title, telephone number, e-mail address, city, state and
country. The registration details will be emailed to you upon receipt
of the above information.

Frost & Sullivan, the Growth Partnership Company, partners with
clients to accelerate their growth. The company's TEAM Research,
Growth Consulting and Growth Team Membership(TM) empower clients to
create a growth-focused culture that generates, evaluates and
implements effective growth strategies. Frost & Sullivan employs over
45 years of experience in partnering with Global 1000 companies,
emerging businesses and the investment community from more than 30
offices on six continents. For more information about Frost &
Sullivan's Growth Partnerships, visit http://www.frost.com.

Frost & Sullivan
Corporate Communications - Africa & Europe Healthcare:
Patrick Cairns, +27 83 258 4219
patrick.cairns@frost.com

Copyright Business Wire 2008